The DOI matches its Crossref record.
Protective Effect of BCG against Tuberculous Meningitis and Miliary Tuberculosis: A Meta-Analysis
Abstract
The protective effect of BCG against tuberculosis (TB) estimated in randomized controlled trials and observational studies ranges from negative to close to a 100%. One of the many explanations offered for this is that different immunological mechanisms may be associated with protective effect against different forms and sites of disease. In this investigation, we recalculated vaccine protective effect separately for pulmonary disease and for meningeal/miliary disease in randomized controlled trials and case-control studies, tested for heterogeneity in site-specific estimates of protective effect and calculated a summary measure when appropriate. We found protective effect against pulmonary disease to be heterogeneous to a statistically significant degree, and thus we did not calculate a summary measure of protection. Protective effect against meningeal and miliary TB was higher than against pulmonary disease and, except for a single study with two cases only, appeared to be homogenous. Summary BCG protective effect against miliary or meningeal TB in randomized controlled trials was 86% (95% confidence interval [CI] 65, 95) and in case-control studies 75% (95% CI: 61, 84). The fact that protective effect appeared to be homogeneous against meningitis and miliary TB but not against pulmonary disease may result from the fact that patients with meningitis are on average younger and thus less likely to have been exposed to atypical bacteria; to a waning of the protective effect of BCG; or from the diversity of mechanisms of pathogenesis of pulmonary disease, which can originate from reinfection, reactivation or primary progression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Variation in protection by BCG: implications of and for heterologous immunity
Fine, P. E. M. (1995) · The Lancet · doi:10.1016/s0140-6736(95)92348-9 · Cited by 1,380
(2005) · PsycEXTRA Dataset · doi:10.1037/e545842006-001 · Cited by 1,274
Trunz, B. B., Fine, P., & Dye, C. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68507-3 · Cited by 1,114
Tameris, M. D., Hatherill, M., Landry, B. S., Scriba, T. J., Snowden, M. A., Lockhart, S., Shea, J. E., McClain, J. B., Hussey, G. D., Hanekom, W. A., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(13)60177-4 · Cited by 1,049
Protection by BCG vaccine against tuberculosis: a systematic review of randomized controlled trials
Mangtani, P., Abubakar, I., Ariti, C., Beynon, R., Pimpin, L., Fine, P. E. M., Rodrigues, L. C., Smith, P. G., Lipman, M., Whiting, P. F., et al. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/cit790 · Cited by 995
Self-citationCentral Nervous System Tuberculosis: Pathogenesis and Clinical Aspects
Rock, R. B., Olin, M., Baker, C. A., Molitor, T. W., & Peterson, P. K. (2008) · Clinical Microbiology Reviews · doi:10.1128/cmr.00042-07 · Cited by 763
Epidemiology of Extrapulmonary Tuberculosis in the United States, 1993–2006
Peto, H. M., Pratt, R. H., Harrington, T. A., LoBue, P. A., & Armstrong, L. R. (2009) · Clinical Infectious Diseases · doi:10.1086/605559 · Cited by 741
“meningeal or disseminated tuberculosis [31].”
McShane, H., Pathan, A. A., Sander, C. R., Keating, S. M., Gilbert, S. C., Huygen, K., Fletcher, H. A., & Hill, A. V. S. (2004) · Nature Medicine · doi:10.1038/nm1128 · Cited by 570
Abubakar, I., Pimpin, L., Ariti, C., Beynon, R., Mangtani, P., Sterne, J., Fine, P., Smith, P., Lipman, M., Elliman, D., et al. (2013) · Health Technol Assess · doi:10.3310/hta17370 · Cited by 498
Self-citationNewton, S. M., Brent, A. J., Anderson, S., Whittaker, E., & Kampmann, B. (2008) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(08)70182-8 · Cited by 480
GlaxoSmithKline Adjuvant Systems in vaccines: concepts, achievements and perspectives
Garçon, N., Chomez, P., & Van Mechelen, M. (2007) · Expert Review of Vaccines · doi:10.1586/14760584.6.5.723 · Cited by 476
Miliary tuberculosis: new insights into an old disease
Sharma, S. K., Mohan, A., Sharma, A., & Mitra, D. K. (2005) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(05)70163-8 · Cited by 438
Horwitz, M. A., Harth, G., Dillon, B. J., & Masleša-Galić, S. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.250480397 · Cited by 436
Kristensen, I., Aaby, P., Jensen, H., & Fine, P. (2000) · BMJ · doi:10.1136/bmj.321.7274.1435 · Cited by 404
Adaptive Immune Response of Vγ2Vδ2 + T Cells During Mycobacterial Infections
Shen, Y., Zhou, D., Qiu, L., Lai, X., Simon, M., Shen, L., Kou, Z., Wang, Q., Jiang, L., Estep, J., et al. (2002) · Science · doi:10.1126/science.1068819 · Cited by 385
Burden of childhood tuberculosis in 22 high-burden countries: a mathematical modelling study
Dodd, P. J., Gardiner, E., Coghlan, R., & Seddon, J. A. (2014) · The Lancet Global Health · doi:10.1016/s2214-109x(14)70245-1 · Cited by 370
Control and prevention of tuberculosis in the United Kingdom: Code of Practice 2000
Joint Tuberculosis Committee of the British Thoracic Society (2000) · Thorax · doi:10.1136/thorax.55.11.887 · Cited by 366
Long-term Efficacy of BCG Vaccine in American Indians and Alaska Natives: A 60-Year Follow-up Study
Aronson, N. E., Santosham, M., Comstock, G. W., Howard, R. S., Moulton, L. H., Rhoades, E. R., & Harrison, L. H. (2004) · JAMA · doi:10.1001/jama.291.17.2086 · Cited by 338
Immunology of Mycobacterium tuberculosis Infections
Sia, J. K., & Rengarajan, J. (2019) · Microbiology Spectrum · doi:10.1128/microbiolspec.gpp3-0022-2018 · Cited by 312
The risk of disseminated Bacille Calmette-Guerin (BCG) disease in HIV-infected children
Hesseling, A. C., Marais, B. J., Gie, R. P., Schaaf, H. S., Fine, P. E. M., Godfrey-Faussett, P., & Beyers, N. (2007) · Vaccine · doi:10.1016/j.vaccine.2006.07.020 · Cited by 294
Soysal, A., Millington, K. A., Bakir, M., Dosanjh, D., Aslan, Y., Deeks, J. J., Efe, S., Staveley, I., Ewer, K., & Lalvani, A. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67534-4 · Cited by 291
Rodrigues, L. C., Pereira, S. M., Cunha, S. S., Genser, B., Ichihara, M. Y., de Brito, S. C., Hijjar, M. A., Cruz, A. A., Sant'Anna, C., Bierrenbach, A. L., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67145-0 · Cited by 286
Self-citationA Critical Role for CD8 T Cells in a Nonhuman Primate Model of Tuberculosis
Chen, C. Y., Huang, D., Wang, R. C., Shen, L., Zeng, G., Yao, S., Shen, Y., Halliday, L., Fortman, J., McAllister, M., et al. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000392 · Cited by 278
Guideline for Infection Control in Healthcare Personnel, 1998
Bolyard, E. A., Tablan, O. C., Williams, W. W., Pearson, M. L., Shapiro, C. N., Deitchman, S. D., & Hospital Infection Control Practices Advisory Committee (1998) · Infection Control & Hospital Epidemiology · doi:10.1086/647840 · Cited by 277
Nguipdop-Djomo, P., Heldal, E., Rodrigues, L. C., Abubakar, I., & Mangtani, P. (2016) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(15)00400-4 · Cited by 202
Self-citation
Metadata
- Authors
- RODRIGUES, L. C., DIWAN, V. K., & WHEELER, J. G.
- Venue
- International Journal of Epidemiology
- Publisher
- Oxford University Press (OUP)
- Published
- 1993
- Volume
- 22
- Issue
- 6
- Pages
- 1154-1158
- ISSN
- 0300-5771 (ISSN-L)
- 1464-3685
- OpenAlex
- W2123643891
- Cited by
- 650
- References
- 0
- FWCI
- 3.56
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.